Skip to main content
SpringerLink
Log in

Endocannabinoid Modulation of Memory for Emotionally Arousing Experiences

  • Chapter
  • First Online:
Cannabinoid Modulation of Emotion, Memory, and Motivation

  • 1480 Accesses

Abstract

There is extensive evidence that the endocannabinoid system is a key modulator of memory for emotionally arousing experiences. We have demonstrated that endocannabinoids play an essential role in regulating glucocorticoid effects on different memory processes.

In this chapter we will summarize findings describing cannabinoid effects on emotional memory acquisition, consolidation, retrieval and extinction. Then, we will present evidence indicating a critical involvement of the endocannabinoid system in mediating stress effects on memory. Finally, we will describe how endocannabinoids bidirectionally modulate memory processes depending on the level of stress at the time of drug administration, raising the possibility that endocannabinoids may act as an emotional buffer modulating stress effects on memory for emotional experiences.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Akirav I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci. 2011;5:34.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL, Cuomo V. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A. 2009;106(12):4888–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev. 2009;89(1):309–80.

    Article  CAS  PubMed  Google Scholar 

  4. Marsicano G, Lafenetre P. Roles of the endocannabinoid system in learning and memory. Curr Top Behav Neurosci. 2009;1:201–30.

    Article  CAS  PubMed  Google Scholar 

  5. Wotjak CT. Role of endogenous cannabinoids in cognition and emotionality. Mini Rev Med Chem. 2005;5(7):659–70.

    Article  CAS  PubMed  Google Scholar 

  6. Campolongo P, Ratano P, Manduca A, Scattoni ML, Palmery M, Trezza V, Cuomo V. The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front Behav Neurosci. 2012;6:11.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, Goldberg S. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl). 2009;204(4):607–16.

    Article  CAS  Google Scholar 

  8. Szuster RR, Pontius EB, Campos PE. Marijuana sensitivity and panic anxiety. J Clin Psychiatry. 1988;49(11):427–9.

    CAS  PubMed  Google Scholar 

  9. Zanettini C, Panlilio LV, Alicki M, Goldberg SR, Haller J, Yasar S. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci. 2011;5:57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–9.

    Article  CAS  PubMed  Google Scholar 

  11. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A. 1990;87(5):1932–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346(6284):561–4.

    Article  CAS  PubMed  Google Scholar 

  13. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995;215(1):89–97.

    Article  CAS  PubMed  Google Scholar 

  14. Turu G, Hunyady L. Signal transduction of the CB1 cannabinoid receptor. J Mol Endocrinol. 2010;44(2):75–85.

    Article  CAS  PubMed  Google Scholar 

  15. Fu J, Bottegoni G, Sasso O, Bertorelli R, Rocchia W, Masetti M, Guijarro A, Lodola A, Armirotti A, Garau G, Bandiera T, Reggiani A, Mor M, Cavalli A, Piomelli D. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci. 2011;15(1):64–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem. 1997;69(2):631–8.

    Article  CAS  PubMed  Google Scholar 

  17. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54(2):161–202.

    Article  CAS  PubMed  Google Scholar 

  18. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310(5746):329–32.

    Article  PubMed  CAS  Google Scholar 

  19. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci. 2006;1074:514–36.

    Article  CAS  PubMed  Google Scholar 

  20. Marsicano G, Kuner R. Anatomical distribution of receptors, ligands and enzymes in the brain and the spinal cord: circuitries and neurochemistry. In: Kofalvi A, editor. Cannabinoids and the brain. New York: Springer; 2008. pp. 161–202.

    Chapter  Google Scholar 

  21. McPartland JM, Glass M, Pertwee RG. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br J Pharmacol. 2007;152(5):583–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kamprath K, Romo-Parra H, Haring M, Gaburro S, Doengi M, Lutz B, Pape HC. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology. 2010;36(3):652–63.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Ramikie TS, Patel S. Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress. Neuroscience. 2012;204:38–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 1997;277(5329):1094–7.

    Article  CAS  PubMed  Google Scholar 

  25. Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, Duranti A, Tontini A, Piersanti G, Kathuria S, Piomelli D. Cyclohexylcarbamic acid 3’- or 4’-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. J Med Chem. 2004;47(21):4998–5008.

    Article  CAS  PubMed  Google Scholar 

  26. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol. 2009;5(1):36–44.

    Article  CAS  Google Scholar 

  27. Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A. 2009;106(48):20270–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hogestatt ED, Jonsson BA, Ermund A, Andersson DA, Bjork H, Alexander JP, Cravatt BF, Basbaum AI, Zygmunt PM. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem. 2005;280(36):31405–12.

    Article  PubMed  CAS  Google Scholar 

  29. Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol. 2003;139(5):1005–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hauer D, Ratano P, Morena M, Scaccianoce S, Briegel I, Palmery M, Cuomo V, Roozendaal B, Schelling G, Campolongo P. Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology. 2011;114(6):1380–8.

    Article  CAS  PubMed  Google Scholar 

  31. Marsicano G, Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci. 1999;11(12):4213–25.

    Article  CAS  PubMed  Google Scholar 

  32. Azad SC, Kurz J, Marsicano G, Lutz B, Zieglgansberger W, Rammes G. Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learn Mem. 2008;15(3):143–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Morozov YM, Torii M, Rakic P. Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cereb Cortex. 2009;19(Suppl 1):i78–89.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wolfel B, Dodt HU, Zieglgansberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron. 2006;51(4):455–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M, Ohno-Shosaku T, Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci. 2006;26(11):2991–3001.

    Article  CAS  PubMed  Google Scholar 

  36. Haring M, Marsicano G, Lutz B, Monory K. Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience. 2007;146(3):1212–9.

    Article  CAS  PubMed  Google Scholar 

  37. Oropeza VC, Mackie K, Van Bockstaele EJ. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 2007;1127(1):36–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Hermann H, Marsicano G, Lutz B. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience. 2002;109(3):451–60.

    Article  CAS  PubMed  Google Scholar 

  39. Chevaleyre V, Takahashi KA, Castillo PE. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci. 2006;29:37–76.

    Article  CAS  PubMed  Google Scholar 

  40. Katona I, Freund TF. Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci. 2012;35:529–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Marsicano G, Lutz B. Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest. 2006;29(3 Suppl):27–46.

    CAS  PubMed  Google Scholar 

  42. Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology. 2004;46(1):115–25.

    Article  CAS  PubMed  Google Scholar 

  43. Ranganathan M, D’Souza DC. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl). 2006;188(4):425–44.

    Article  CAS  Google Scholar 

  44. Riedel G, Davies SN. Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol. 2005;168:445–77.

    Article  CAS  PubMed  Google Scholar 

  45. Verdejo-Garcia A, Bechara A, Recknor EC, Perez-Garcia M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc. 2006;12(3):405–15.

    Article  PubMed  Google Scholar 

  46. Fisk JE, Montgomery C. Real-world memory and executive processes in cannabis users and non-users. J Psychopharmacol. 2008;22(7):727–36.

    Article  CAS  PubMed  Google Scholar 

  47. Karila L, Roux P, Rolland B, Benyamina A, Reynaud M, Aubin HJ, Lancon C. Acute and long-term effects of cannabis use: a review. Curr Pharm Des. 2014;20(25):4112–8.

    Article  CAS  PubMed  Google Scholar 

  48. Lichtman AH, Dimen KR, Martin BR. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berl). 1995;119(3):282–90.

    Article  CAS  Google Scholar 

  49. Da S, Takahashi RN. SR 141716A prevents delta9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(2):321–5.

    Article  PubMed  Google Scholar 

  50. Pamplona FA, Takahashi RN. WIN 55212–2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett. 2006;397(1–2):88–92.

    Article  CAS  PubMed  Google Scholar 

  51. Robinson L, McKillop-Smith S, Ross NL, Pertwee RG, Hampson RE, Platt B, Riedel G. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berl). 2008;198(4):551–63.

    Article  CAS  Google Scholar 

  52. Mazzola C, Medalie J, Scherma M, Panlilio LV, Solinas M, Tanda G, Drago F, Cadet JL, Goldberg SR, Yasar S. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem. 2009;16(5):332–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Egashira N, Mishima K, Iwasaki K, Fujiwara M. Intracerebral microinjections of delta9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res. 2002;952(2):239–45.

    Article  CAS  PubMed  Google Scholar 

  54. Wegener N, Kuhnert S, Thuns A, Roese R, Koch M. Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats. Psychopharmacology (Berl). 2008;198(3):375–85.

    Article  CAS  Google Scholar 

  55. Abush H, Akirav I. Cannabinoids modulate hippocampal memory and plasticity. Hippocampus. 2010;20(10):1126–38.

    Article  CAS  PubMed  Google Scholar 

  56. Tan H, Lauzon NM, Bishop SF, Chi N, Bechard M, Laviolette SR. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci. 2011;31(14):5300–12.

    Article  CAS  PubMed  Google Scholar 

  57. Mackowiak M, Chocyk A, Dudys D, Wedzony K. Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience. 2009;158(4):1708–16.

    Article  CAS  PubMed  Google Scholar 

  58. Yim TT, Hong NS, Ejaredar M, McKenna JE, McDonald RJ. Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus. Neuroscience. 2008;151(4):929–36.

    Article  CAS  PubMed  Google Scholar 

  59. Busquets-Garcia A, Puighermanal E, Pastor A, de la Torre R, Maldonado R, Ozaita A. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol Psychiatry. 2011;70(5):479–86.

    Article  CAS  PubMed  Google Scholar 

  60. Wise LE, Iredale PA, Lichtman AH. The cannabinoid CB(1) receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task. Eur J Pharmacol. 2008;590(1–3):246–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Wolff MC, Leander JD. SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur J Pharmacol. 2003;477(3):213–7.

    Article  CAS  PubMed  Google Scholar 

  62. Jamali-Raeufy N, Nasehi M, Zarrindast MR. Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus. Behav Pharmacol. 2011;22(7):645–54.

    Article  CAS  PubMed  Google Scholar 

  63. Zarrindast MR, Navaeian M, Nasehi M. Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats. Neurosci Res. 2011;69(1):51–9.

    Article  CAS  PubMed  Google Scholar 

  64. De Oliveira Alvares L, Genro BP, Diehl F, Quillfeldt JA. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiol Learn Mem. 2008;90(1):1–9.

    Article  PubMed  CAS  Google Scholar 

  65. Mishima K, Egashira N, Hirosawa N, Fujii M, Matsumoto Y, Iwasaki K, Fujiwara M. Characteristics of learning and memory impairment induced by ∆9-Tetrahydrocannabinol in rats. Jpn J Pharmacol. 2001;87:297–308.

    Article  CAS  PubMed  Google Scholar 

  66. Niyuhire F, Varvel SA, Martin BR, Lichtman AH. Exposure to marijuana smoke impairs memory retrieval in mice. J Pharmacol Exp Ther. 2007;322(3):1067–75.

    Article  CAS  PubMed  Google Scholar 

  67. Atsak P, Hauer D, Campolongo P, Schelling G, McGaugh JL, Roozendaal B. Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Proc Natl Acad Sci U S A. 2012;109(9):3504–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Piri M, Zarrindast MR. Modulation of WIN55,212-2 state-dependent memory by alpha2-adrenergic receptors of the dorsal hippocampus. Arch Iran Med. 2011;14(6):389–95.

    CAS  PubMed  Google Scholar 

  69. Segev A, Akirav I. Differential effects of cannabinoid receptor agonist on social discrimination and contextual fear in amygdala and hippocampus. Learn Mem. 2011;18(4):254–9.

    Article  CAS  PubMed  Google Scholar 

  70. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002;418(6897):530–4.

    Article  CAS  PubMed  Google Scholar 

  71. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci. 2004;24(20):4787–95.

    Article  CAS  PubMed  Google Scholar 

  72. Pamplona FA, Prediger RD, Pandolfo P, Takahashi RN. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl). 2006;188(4):641–9.

    Article  CAS  Google Scholar 

  73. Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005;30(3):516–24.

    Article  CAS  PubMed  Google Scholar 

  74. Barad M, Gean PW, Lutz B. The role of the amygdala in the extinction of conditioned fear. Biol Psychiatry. 2006;60(4):322–8.

    Article  PubMed  Google Scholar 

  75. Niyuhire F, Varvel SA, Thorpe AJ, Stokes RJ, Wiley JL, Lichtman AH. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific. Psychopharmacology (Berl). 2007;191(2):223–31.

    Article  CAS  Google Scholar 

  76. Morena M, Campolongo P. The endocannabinoid system: an emotional buffer in the modulation of memory function. Neurobiol Learn Mem. 2014;112C:30–43.

    Article  CAS  Google Scholar 

  77. McGaugh JL. Memory–a century of consolidation. Science. 2000;287(5451):248–51.

    Article  CAS  PubMed  Google Scholar 

  78. Cahill L. Neurobiological mechanisms of emotionally influenced, long-term memory. Prog Brain Res. 2000;126:29–37.

    Article  CAS  PubMed  Google Scholar 

  79. Cahill L, McGaugh JL, Weinberger NM. The neurobiology of learning and memory: some reminders to remember. Trends Neurosci. 2001;24(10):578–81.

    Article  CAS  PubMed  Google Scholar 

  80. Dolcos F, LaBar KS, Cabeza R. Remembering one year later: role of the amygdala and the medial temporal lobe memory system in retrieving emotional memories. Proc Natl Acad Sci U S A. 2005;102(7):2626–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2010;35(1):192–216.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Packard MG, Wingard JC. Amygdala and “emotional” modulation of the relative use of multiple memory systems. Neurobiol Learn Mem. 2004;82(3):243–52.

    Article  PubMed  Google Scholar 

  83. Aggleton JP. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 1993;16(8):328–33.

    Article  CAS  PubMed  Google Scholar 

  84. Davis M, Rainnie D, Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 1994;17(5):208–14.

    Article  CAS  PubMed  Google Scholar 

  85. Baxter MG, Murray EA. The amygdala and reward. Nat Rev Neurosci. 2002;3(7):563–73.

    Article  CAS  PubMed  Google Scholar 

  86. Pape HC, Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev. 2010;90(2):419–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci. 2009;10(3):211–23.

    Article  CAS  PubMed  Google Scholar 

  88. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985;117(6):2505–11.

    Article  CAS  PubMed  Google Scholar 

  89. Joels M, Baram TZ. The neuro-symphony of stress. Nat Rev Neurosci. 2009;10(6):459–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Tasker JG, Di S, Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology. 2006;147(12):5549–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. de Kloet ER, Oitzl MS, Joels M. Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci. 1999;22(10):422–6.

    Article  PubMed  Google Scholar 

  92. Oitzl MS, de Kloet ER. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci. 1992;106(1):62–71.

    Article  CAS  PubMed  Google Scholar 

  93. Roozendaal B. 1999 Curt P. Richter award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology. 2000;25(3):213–38.

    Article  CAS  PubMed  Google Scholar 

  94. Sandi C, Rose SP. Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm. Brain Res. 1994;647(1):106–12.

    Article  CAS  PubMed  Google Scholar 

  95. De Boer SF Koopmans SJ, Slangen JL, Van der Gugten J. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: effect of interstressor interval length. Physiol Behav. 1990;47(6):1117–24.

    Article  CAS  PubMed  Google Scholar 

  96. de Quervain DJ, Aerni A, Schelling G, Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Front Neuroendocrinol. 2009;30(3):358–70.

    Article  PubMed  CAS  Google Scholar 

  97. de Quervain DJ, Roozendaal B, McGaugh JL. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature. 1998;394(6695):787–90.

    Article  PubMed  CAS  Google Scholar 

  98. Roozendaal B, de Quervain DJ, Schelling G, McGaugh JL. A systemically administered beta-adrenoceptor antagonist blocks corticosterone-induced impairment of contextual memory retrieval in rats. Neurobiol Learn Mem. 2004;81(2):150–4.

    Article  CAS  PubMed  Google Scholar 

  99. Roozendaal B, McGaugh JL. Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task. Neurobiol Learn Mem. 1996;65(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  100. Quirarte GL, Galvez R, Roozendaal B, McGaugh JL. Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res. 1998;808(2):134–40.

    Article  CAS  PubMed  Google Scholar 

  101. Galvez R, Mesches MH, McGaugh JL. Norepinephrine release in the amygdala in response to footshock stimulation. Neurobiol Learn Mem. 1996;66(3):253–7.

    Article  CAS  PubMed  Google Scholar 

  102. McIntyre CK, Hatfield T, McGaugh JL. Amygdala norepinephrine levels after training predict inhibitory avoidance retention performance in rats. Eur J Neurosci. 2002;16(7):1223–6.

    Article  PubMed  Google Scholar 

  103. Quirarte GL, Roozendaal B, McGaugh JL. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A. 1997;94(25):14048–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Roozendaal B, Quirarte GL, McGaugh JL. Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor–cAMP/cAMP/PKA system in influencing memory consolidation. Eur J Neurosci. 2002;15(3):553–60.

    Article  PubMed  Google Scholar 

  105. Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat Rev Neurosci. 2009;10(6):423–33.

    Article  CAS  PubMed  Google Scholar 

  106. Okuda S, Roozendaal B, McGaugh JL. Glucocorticoid effects on object recognition memory require training-associated emotional arousal. Proc Natl Acad Sci U S A. 2004;101(3):853–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Roozendaal B. Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem. 2002;78(3):578–95.

    Article  CAS  PubMed  Google Scholar 

  108. Hill MN, McEwen BS. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(5):791–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci. 2003;23(12):4850–7.

    CAS  PubMed  Google Scholar 

  110. Di S, Malcher-Lopes R, Marcheselli VL, Bazan NG, Tasker JG. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology. 2005;146(10):4292–301.

    Article  CAS  PubMed  Google Scholar 

  111. Derbenev AV, Stuart TC, Smith BN. Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve. J Physiol. 2004;559(Pt 3):923–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991;11(2):563–83.

    CAS  PubMed  Google Scholar 

  113. Jelsing J, Larsen PJ, Vrang N. Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. Neuroscience. 2008;154(2):641–52.

    Article  CAS  PubMed  Google Scholar 

  114. Mailleux P, Vanderhaeghen JJ. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 1992;48(3):655–68.

    Article  CAS  PubMed  Google Scholar 

  115. Matsuda LA, Bonner TI, Lolait SJ. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol. 1993;327(4):535–50.

    Article  CAS  PubMed  Google Scholar 

  116. Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur J Neurosci. 2006;23(9):2385–94.

    Article  PubMed  Google Scholar 

  117. Oropeza VC, Page ME, Van Bockstaele EJ. Systemic administration of WIN 55,212–2 increases norepinephrine release in the rat frontal cortex. Brain Res. 2005;1046(1–2):45–54.

    Article  CAS  PubMed  Google Scholar 

  118. Page ME, Oropeza VC, Sparks SE, Qian Y, Menko AS, Van Bockstaele EJ. Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacol Biochem Behav. 2007;86(1):162–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. de Oliveira, Alvares L, Engelke DS, Diehl F, Scheffer-Teixeira R, Haubrich J, de Freitas Cassini L, Molina VA, Quillfeldt JA. Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory. Learn Mem. 2010;17(4):202–9.

    Google Scholar 

  120. Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci. 2010;30(45):14980–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Campolongo P, Roozendaal B, Trezza V, Cuomo V, Astarita G, Fu J, McGaugh JL, Piomelli D. Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proc Natl Acad Sci U S A. 2009;106(19):8027–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Kuhlmann S, Piel M, Wolf OT. Impaired memory retrieval after psychosocial stress in healthy young men. J Neurosci. 2005;25(11):2977–82.

    Article  CAS  PubMed  Google Scholar 

  123. Ballard ME, Bedi G, de Wit H. Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. J Psychopharmacol. 2012;26(10):1289–98.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  124. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 1998;83(2):393–411.

    Article  CAS  PubMed  Google Scholar 

  125. Campolongo P, Morena M, Scaccianoce S, Trezza V, Chiarotti F, Schelling G, Cuomo V, Roozendaal B. Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity. Neuropsychopharmacology. 2013;38:1276–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A. 2006;103(17):6741–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Patel S, Hillard CJ. Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Res. 2003;963(1–2):15–25.

    Article  CAS  PubMed  Google Scholar 

  128. Carvalho AF, Van Bockstaele EJ. Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38(1):59–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Maroun M, Akirav I. Arousal and stress effects on consolidation and reconsolidation of recognition memory. Neuropsychopharmacology. 2008;33(2):394–405.

    Article  CAS  PubMed  Google Scholar 

  130. Ganon-Elazar E, Akirav I. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci. 2009;29(36):11078–88.

    Article  CAS  PubMed  Google Scholar 

  131. Ramot A, Akirav I. Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience. Neurobiol Learn Mem. 2012;97(4):393–401.

    Article  CAS  PubMed  Google Scholar 

  132. Segev A, Rubin AS, Abush H, Richter-Levin G, Akirav I. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression. Neuropsychopharmacology. 2014;39(4):919–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. McGaugh JL, Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Curr Opin Neurobiol. 2002;12(2):205–10.

    Article  CAS  PubMed  Google Scholar 

  134. Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology. 2010;35(9):1333–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grubler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 2007;148(4):1574–81.

    Article  CAS  PubMed  Google Scholar 

  136. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci. 2001;21(23):9506–18.

    CAS  PubMed  Google Scholar 

  137. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci. 1999;19(11):4544–58.

    CAS  PubMed  Google Scholar 

  138. Ohno-Shosaku T, Maejima T, Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron. 2001;29(3):729–38.

    Article  CAS  PubMed  Google Scholar 

  139. Hatfield T, Spanis C, McGaugh JL. Response of amygdalar norepinephrine to footshock and GABAergic drugs using in vivo microdialysis and HPLC. Brain Res. 1999;835(2):340–5.

    Article  CAS  PubMed  Google Scholar 

  140. Hill MN, Tasker JG. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience. 2012;204:5–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci. 2011;13(1):22–37.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  142. Millan MJ. The neurobiology and control of anxious states. Prog Neurobiol. 2003;70(2):83–244.

    Article  CAS  PubMed  Google Scholar 

  143. Myhrer T. Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev. 2003;41(2–3):268–87.

    Article  CAS  PubMed  Google Scholar 

  144. Metna-Laurent M, Soria-Gómez E, Verrier D, Conforzi M, Jego P, Lafenetre P, Marsicano G. Bimodal control of fear-coping strategies by CB1 cannabinoid receptors. J Neurosci. 2012;32(21):7109–18.

    Article  CAS  PubMed  Google Scholar 

  145. Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J Pharmacol Exp Ther. 2006;316(3):969–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology and Pharmacology, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy

    Maria Morena PhD & Patrizia Campolongo PhD

Authors
  1. Maria Morena PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrizia Campolongo PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrizia Campolongo PhD .

Editor information

Editors and Affiliations

  1. Dept. of Physiology and Pharmacology, Sapienza University, Rome, Italy

    Patrizia Campolongo

  2. Institute of Neuroscience CNR, University of Cagliari, Cagliari, Italy

    Liana Fattore

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Morena, M., Campolongo, P. (2015). Endocannabinoid Modulation of Memory for Emotionally Arousing Experiences. In: Campolongo, P., Fattore, L. (eds) Cannabinoid Modulation of Emotion, Memory, and Motivation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2294-9_1

Download citation

Publish with us

Policies and ethics

Search

Navigation